Transdiagnostic Cognitive Biomarkers
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Arm 1, healthy controls: Inclusion Criteria: * Have access to the online study platform. Exclusion Criteria: * under 18, non-English speaking Arm 2: pain and depression: Inclusion Criteria: * Pain or depression Exclusion Criteria: * pregnant women
About the study
The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.
What is being tested
- Computer game/task (behavioral)
- Health surveys online (behavioral)
Sponsor: University of Minnesota · Participants: 48 · Started: Apr 11, 2022
Contact the study team
- David Darrow · Phone: (612) 624-6666
- MATTHEW D Maple · Phone: 612-946-1424
Official record on ClinicalTrials.gov — NCT04864080
Locations in the U.S.
| Minnesota | University of Minnesota, Minneapolis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.